Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer

Willenbrock, F, Cox, CM, Parkes, EE et al. (10 more authors) (2021) Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer. British Journal of Cancer, 124 (3). pp. 581-586. ISSN 0007-0920

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Willenbrock, F
  • Cox, CM
  • Parkes, EE
  • Wilhelm-Benartzi, CS
  • Abraham, AG
  • Owens, R
  • Sabbagh, A
  • Jones, CM
  • Hughes, DLI
  • Maughan, T
  • Hurt, CN
  • O’Neill, EE
  • Mukherjee, S
Copyright, Publisher and Additional Information:

© 2020, The Author(s), under exclusive licence to Cancer Research UK. This is an author produced version of an article published in British Journal of Cancer. Uploaded in accordance with the publisher's self-archiving policy.

Dates:
  • Published: 2 February 2021
  • Published (online): 26 October 2020
  • Accepted: 2 October 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 03 Nov 2020 14:58
Last Modified: 18 Jul 2022 10:45
Status: Published
Publisher: Springer Nature
Identification Number: 10.1038/s41416-020-01120-z
Open Archives Initiative ID (OAI ID):

Export

Statistics